These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2877543)

  • 21. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
    Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
    Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis].
    Raevskiĭ KS; Shemanov AIu; Kudrin VS
    Farmakol Toksikol; 1982; 45(5):5-8. PubMed ID: 6128254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
    Kanes SJ; Hitzemann BA; Hitzemann RJ
    J Pharmacol Exp Ther; 1993 Oct; 267(1):538-47. PubMed ID: 7901398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic interactions between ampakines and antipsychotic drugs.
    Johnson SA; Luu NT; Herbst TA; Knapp R; Lutz D; Arai A; Rogers GA; Lynch G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):392-7. PubMed ID: 10087029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of neuroleptics on foot-pedal self stimulation from the ventral tegmentum mesencephali in rats and its correlation with cataleptogenic action].
    Talalaenko AN; Boreĭsha IK; Zin'kovskaia LIa
    Farmakol Toksikol; 1982; 45(2):19-22. PubMed ID: 6122595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between some biochemical and behavioural effects produced by neuroleptics.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.
    Ossowska K; Pietraszek M; Wardas J; Wolfarth S
    Pol J Pharmacol; 2004; 56(3):295-304. PubMed ID: 15215559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.
    Roth KA; McIntire SL; Barchas JD
    J Pharmacol Exp Ther; 1982 May; 221(2):416-20. PubMed ID: 7077536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptics and antidepressive agents].
    Kreiskott H; Kretzschmar R; Teschendorf HJ
    Arzneimittelforschung; 1981; Suppl 27():34-44. PubMed ID: 6118159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modification, by lithium, of catalepsy induced by central cholinergic stimulants and morphine-like drugs].
    Scotto di Tella AM
    C R Seances Soc Biol Fil; 1981; 175(3):357-63. PubMed ID: 6268258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
    Marchese G; Casu G; Casti P; Spada GP; Pani L
    Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Participation of brain cholinergic mechanisms in the action of neuroleptics].
    Gromov AI
    Farmakol Toksikol; 1975; 38(2):145-8. PubMed ID: 1241675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Increase in the affinity of rat brain M-cholinergic receptors upon one-time administration of the cholinolytic, amizyl].
    Malygin VV; Evdokimenko SG; Serebriakova OG; Martynov IV
    Dokl Akad Nauk SSSR; 1991; 317(5):1261-4. PubMed ID: 1743090
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of tiapride on the activity of neuroleptics and other kinds of drugs in mice and rats].
    Satoh H; Terai T; Nakanishi H; Ono T; Shibayama F
    Nihon Yakurigaku Zasshi; 1988 Feb; 91(2):71-80. PubMed ID: 2897321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural actions of neuroleptics are not reduced by hypophysectomy.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    J Pharm Pharmacol; 1982 Sep; 34(9):588-90. PubMed ID: 6127386
    [No Abstract]   [Full Text] [Related]  

  • 40. GABA involvement in neuroleptic-induced catalepsy.
    Worms P; Willigens MT; Lloyd KG
    J Pharm Pharmacol; 1978 Nov; 30(11):716-8. PubMed ID: 31437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.